SCHEMBL3311066

SCHEMBL3311066

C=C(C)O[C@H](C(=O)O)c1c(C)cc2c(ccc(=O)n2Cc2ccncc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
PDE5A O76074 1/20 0.36
KCNH2 Q12809 1/20 0.35
SLC16A3 O15427 1/20 0.34
PTGDR2 Q9Y5Y4 2/20 0.33
ALOX5 P09917 1/20 0.33
ALOX5AP P20292 1/20 0.33
MDM2 Q00987 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PTGES2 Q9H7Z7 2/20 0.32
PTGES O14684 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
S1PR3 Q99500 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3312482 0.92 PTGDR2 (0.40) KDM4EPTGDR2MDM2MEN1KMT2A
SCHEMBL15186207 0.87 CYP3A4 (0.42) KDM4EPDE5AKCNH2SLC16A3ALOX5
SCHEMBL3312494 0.86 CYP3A4 (0.32) KDM4EPTGDR2NPC1LMNACYP3A4
SCHEMBL15182600 0.84 KDM4E (0.37) KDM4EPDE5AKCNH2SLC16A3PTGDR2
SCHEMBL3297264 0.79 CYP3A4 (0.42) KCNH2PTGDR2ALOX5MDM2MEN1
SCHEMBL15182599 0.77 PTGES2 (0.41) KDM4EPTGDR2MDM2MEN1KMT2A
SCHEMBL3301651 0.76 CYP3A4 (0.36) KDM4EKMT2ACYP3A4
SCHEMBL15182601 0.74 CYP3A4 (0.41) KDM4EKCNH2SLC16A3PTGDR2NPC1
SCHEMBL10284000 0.74 KMT2A (0.35) KDM4ENPC1SMN1; SMN2MEN1KMT2A
SCHEMBL15102812 0.74 PPARG (0.43) KCNH2ALOX5CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003498-A1 2 -QUINOLINYL- ACETIC ACID DERIVATIVES AS HIV ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-01-05 WO disclosed